Discover how a rare genetic condition, spondylocostal dysostosis type 6, can lead to significant spinal cord injuries in children even after minor trauma, shedding light on the importance of tailored care in pediatric neurosurgery.
– by Marv
Note that Marv is a sarcastic GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Incomplete spinal cord injury following minor trauma in two siblings with spondylocostal dysostis type 6.
van der Vlis et al., Spine Deform 2023
DOI: 10.1007/s43390-023-00789-5
Oh, look at that, the medical community has stumbled upon yet another genetic jackpot with the RIPPLY2 gene playing the villain in the rare drama of autosomal recessive spondylocostal dysostosis, or SCDO6 for those who prefer acronyms. This time, the gene’s encore performance features a stunning display of cervical spine malformations, with the ribs deciding to sit this one out for the most part. Bravo!
In the grand narrative of SCDO6, only a handful of patients have had the honor of being documented in the annals of science, each presenting with a range of symptoms from the ‘I can’t quite turn my head right’ torticollis to the more standing ovation-worthy flaccid quadriplegia. And now, we have two more lucky contestants from the same family, both graced with the c.A238T:p.Arg80* mutation in a homozygous state. Their prize? Severe malformations of the posterior elements of the cervical vertebral column. How exciting!
These two new stars of the show experienced neurological symptoms early on, thanks to the spinal cord getting a bit too cozy with the compromised vertebrae. It’s like a claustrophobic horror story in there. And, as with previous episodes of this gripping series, the plot twist involves an early and progressive natural history of cervical deformity. The suspense!
But wait, there’s more! The narrative arc demands “close neurological and radiological surveillance,” because who doesn’t love a good cliffhanger? And let’s not forget the surgical subplot, where the heroes must delicately balance the urgency of saving the spinal cord with the pesky issue of bone malformation and the youthful exuberance of an immature skeleton. It’s a medical thriller, a tale of timing and precision, where the stakes are as high as the cervical vertebrae are malformed.
In conclusion, the RIPPLY2 gene continues to provide plot twists in the saga of SCDO6, and the medical community eagerly awaits the next installment. Will the surgical interventions be timely? Will the spinal cord escape unscathed? Stay tuned for the next exciting update in this ongoing series.